Search

Your search keyword '"Gilard, M."' showing total 551 results

Search Constraints

Start Over You searched for: Author "Gilard, M." Remove constraint Author: "Gilard, M."
551 results on '"Gilard, M."'

Search Results

3. Routine CYP2C19 Genotyping to Adjust Thienopyridine Treatment After Primary PCI for STEMI: Results of the GIANT Study

4. Aktualizace Doporučení ESC pro diagnostiku a léčbu akutního a chronického srdečního selhání 2021. Vypracovaná Pracovní skupinou pro diagnostiku a léčbu akutního a chronického srdečního selhání Evropské kardiologické společnosti (ESC). Se zvláštním přispěním Evropské asociace srdečního selhání ESC.

5. Clinical effects of permanent pacemaker implantation after transcatheter aortic valve implantation: Insights from the nationwide France TAVI registry

12. In-hospital outcomes following an acute coronary syndrome in patients with a recent cannabis use: Results from ADDICT-ICCU trial

13. Mitral valve-in-valve and valve-in-ring procedures: Midterm outcomes in a French nationwide registry

14. Characteristics of young women presenting with acute myocardial infarction: the prospective, multicentre, observational WAMIF study

15. Aortic valve replacement for aortic stenosis in France – influence of centers' volumes on TAVR adoption rate and outcomes

18. Interobserver variability in the classification of congenital coronary abnormalities: A substudy of the anomalous connections of the coronary arteries registry

21. JESFC 2022: A unique conference, from face-to-face to digital [JESFC 2022: un congrès unique, du présentiel au digital]

22. Linee guida ESC 2021 per la diagnosi e il trattamento dello scompenso cardiaco acuto e cronico elaborate dalla Task Force per la diagnosi e il trattamento dello scompenso cardiaco acuto e cronico della Società Europea di Cardiologia (ESC) con il contributo straordinario della Heart Failure Association (HFA) dell’ESC = [2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC]

23. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes

26. Transcatheter aortic valve implantation: early results of the FRANCE (FRench Aortic National CoreValve and Edwards) registry

30. Modifying effect of dual antiplatelet therapy on incidence of stent thrombosis according to implanted drug-eluting stent type

31. Editorial to the 31st edition of the Online European Days of the French Society of Cardiology

32. Éditorial de la 31e édition des Journées Européennes online de la Société française de cardiologie

33. 2019 ESC Guide on the Diagnosis and Treatment of Chronic Coronary Syndromes

34. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

35. Debate: Prasugrel rather than ticagrelor is the preferred treatment for NSTE-ACS patients who proceed to PCI and pretreatment should not be performed in patients planned for an early invasive strategy

36. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

37. 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

38. Physiological Evaluation of Anomalous Aortic Origin of a Coronary Artery Using Computed Tomography–Derived Fractional Flow Reserve

41. Prospective study in young women presenting acute MYOCARDIAL infarction in France: Clinical, morphological and biological descriptive analysis: WAMIF Study

42. Predictive value of early cardiac mri functional and geometric indexes on adverse left ventricular remodelling in anterior STEMI patients. A report from the CIRCUS study

43. High post-procedural transvalvular gradient or delayed gradient increase after transcatheter aortic valve implantation: the FRANCE-2 registry

44. Comparison between transthoracic echocardiography and transcranial Doppler for detection of PFO in patients in the acute phase of a pulmonary embolism. A Post-hoc analysis of EPIC-FOP

45. Risk-benefit profile of longer-than-1-year dual-antiplatelet therapy duration after drug-eluting stent implantation in relation to clinical presentation a pairwise meta-analysis of 6 trials and 21 457 patients

46. Routine CYP2C19 Genotyping to Adjust Thienopyridine Treatment After Primary PCI for STEMI

47. A controlled trial of rivaroxaban after transcatheter aortic-valve replacement

48. The Membership Committee of the ESC

49. Recurrent vertigo is a predictor of stroke in a large cohort of hypertensive patients

50. Dual antiplatelet therapy duration after coronary stenting in clinical practice: results of an EAPCI survey

Catalog

Books, media, physical & digital resources